T C M. | INFINIUM PHARMACHEM LTD. | T C M./ INFINIUM PHARMACHEM LTD. |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -13.8 | - | - | View Chart |
P/BV | x | 1.3 | 13.4 | 9.8% | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
T C M. INFINIUM PHARMACHEM LTD. |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
T C M. Mar-23 |
INFINIUM PHARMACHEM LTD. Mar-23 |
T C M./ INFINIUM PHARMACHEM LTD. |
5-Yr Chart Click to enlarge
|
||
High | Rs | 58 | NA | - | |
Low | Rs | 26 | NA | - | |
Sales per share (Unadj.) | Rs | 9.8 | 224.9 | 4.4% | |
Earnings per share (Unadj.) | Rs | -5.7 | 19.3 | -29.6% | |
Cash flow per share (Unadj.) | Rs | -5.2 | 22.0 | -23.7% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 41.1 | 44.4 | 92.5% | |
Shares outstanding (eoy) | m | 7.48 | 5.08 | 147.2% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 4.3 | 0 | - | |
Avg P/E ratio | x | -7.4 | 0 | - | |
P/CF ratio (eoy) | x | -8.1 | 0 | - | |
Price / Book Value ratio | x | 1.0 | 0 | - | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 316 | 0 | - | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 19 | 37 | 50.6% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 73 | 1,142 | 6.4% | |
Other income | Rs m | 0 | 14 | 1.6% | |
Total revenues | Rs m | 74 | 1,156 | 6.4% | |
Gross profit | Rs m | -37 | 160 | -22.9% | |
Depreciation | Rs m | 4 | 13 | 27.8% | |
Interest | Rs m | 3 | 31 | 8.9% | |
Profit before tax | Rs m | -43 | 130 | -33.2% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 0 | 31 | -0.8% | |
Profit after tax | Rs m | -43 | 98 | -43.5% | |
Gross profit margin | % | -49.9 | 14.0 | -355.5% | |
Effective tax rate | % | 0.5 | 24.2 | 2.3% | |
Net profit margin | % | -58.1 | 8.6 | -676.4% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 95 | 513 | 18.4% | |
Current liabilities | Rs m | 191 | 368 | 51.9% | |
Net working cap to sales | % | -130.8 | 12.7 | -1,027.1% | |
Current ratio | x | 0.5 | 1.4 | 35.5% | |
Inventory Days | Days | 191 | 1 | 13,560.8% | |
Debtors Days | Days | 2,331 | 49,313 | 4.7% | |
Net fixed assets | Rs m | 396 | 192 | 206.0% | |
Share capital | Rs m | 75 | 51 | 147.1% | |
"Free" reserves | Rs m | 233 | 175 | 133.1% | |
Net worth | Rs m | 307 | 226 | 136.3% | |
Long term debt | Rs m | 1 | 101 | 0.6% | |
Total assets | Rs m | 688 | 706 | 97.5% | |
Interest coverage | x | -14.6 | 5.2 | -281.6% | |
Debt to equity ratio | x | 0 | 0.4 | 0.4% | |
Sales to assets ratio | x | 0.1 | 1.6 | 6.6% | |
Return on assets | % | -5.8 | 18.3 | -31.7% | |
Return on equity | % | -13.9 | 43.5 | -31.9% | |
Return on capital | % | -13.1 | 49.2 | -26.5% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 297 | 0.0% | |
Fx outflow | Rs m | 16 | 307 | 5.1% | |
Net fx | Rs m | -16 | -10 | 150.7% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | -109 | 86 | -126.5% | |
From Investments | Rs m | 58 | -50 | -117.9% | |
From Financial Activity | Rs m | 49 | -31 | -156.8% | |
Net Cashflow | Rs m | -2 | 5 | -29.4% |
Indian Promoters | % | 49.5 | 73.1 | 67.8% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 7.7 | 0.0 | - | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 50.5 | 27.0 | 187.3% | |
Shareholders | 3,972 | 771 | 515.2% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare T C M. With: PIDILITE INDUSTRIES SRF BALAJI AMINES GHCL YASHO INDUSTRIES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | T C M. | INFINIUM PHARMACHEM LTD. |
---|---|---|
1-Day | 4.41% | -0.41% |
1-Month | -0.15% | -4.22% |
1-Year | 61.88% | -20.12% |
3-Year CAGR | 15.89% | -7.22% |
5-Year CAGR | 12.15% | -4.39% |
* Compound Annual Growth Rate
Here are more details on the T C M. share price and the INFINIUM PHARMACHEM LTD. share price.
Moving on to shareholding structures...
The promoters of T C M. hold a 49.5% stake in the company. In case of INFINIUM PHARMACHEM LTD. the stake stands at 73.1%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of T C M. and the shareholding pattern of INFINIUM PHARMACHEM LTD..
Finally, a word on dividends...
In the most recent financial year, T C M. paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.
INFINIUM PHARMACHEM LTD. paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of T C M., and the dividend history of INFINIUM PHARMACHEM LTD..
After opening the day on positive note, Indian share markets continued the momentum as the session progressed and ended on firm footing.